Express Pharma - Express Pharma

EBITDA for the quarter was Rs 8,003 million compared to Rs 8,267 million in Q4 FY 2017

Develops business continuity plan to handle workload implications and reallocate resources to maintain its priority activities

Both drugs to be manufactured at the company’s formulations manufacturing facility at the Pharma SEZ, Ahmedabad

Acyclovir Ointment USP, 5 per cent is the generic version of Zovirax Ointment, 5 per cent

Consistently delivering excellent set of results quarter after quarter

The deal was announced last July when Shanghai Fosun agreed to buy an 86 per cent stake in KKR & Co-backed Gland Pharma

GBR 830 is an investigational, first-in-class, Anti-OX40 Monoclonal Antibody

Markets and Markets, will organise a seminar on Proactive & Sustainable Compliance Workshop

In Q1 2017-18, company posts revenue of Rs 1,374 crores

Meronem is used for the treatment of serious infections in hospitalised patients